Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$662.1K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 6 most recent Form 4 transactions.
| Jazz Pharmaceuticals plc |
| SSELL |
| 2,741 |
| $241.57 |
| $662.1K |
| -22.3% |
| Open the original filing on SEC.gov |
| May 22 | JAZZ | Jazz Pharmaceuticals plc | MEXER | 3,415 | $138.08 | $471.5K | +38.4% | Open the original filing on SEC.gov |
| May 20 | TBPH | Theravance Biopharma, Inc. | FTAX | 20,038 | $16.55 | $331.6K | -1.2% | Open the original filing on SEC.gov |
| Apr 1 | TBPH | Theravance Biopharma, Inc. | AGRANT | 75,000 | — | — | +4.8% | Open the original filing on SEC.gov |